May 25, 2022CorporateTerumo Blood and Cell Technologies Inaugurates Second Manufacturing Facility in Colorado
May 17, 2022CorporateTerumo Pharmaceutical Solutions Offers Pre-Fillable Syringe Solutions for Demanding Low Dose Applications Such as Ophthalmic
May 16, 2022CorporateTerumo Announces Change in Indication for Dexcom G6 CGM System in Japan Adjunctive use of Blood Glucose Meter Principally Not Required
Refining Searches 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Corporate Financial December 07, 2018 Corporate Terumo Announces European Launch of Biosimilar Using Terumo's PLAJEX™ Pre-fillable Syringes November 14, 2018 Corporate Terumo Cardiovascular Group Announces 510(k) Clearance for the CDI® Blood Parameter Monitoring System 550, Adding New Parameter for Oxygen Delivery Monitoring oxygen delivery helps reduce the incidence of Acute Kidney Injury during cardiac surgery November 14, 2018 Corporate Terumo Announces GMP Certification Has Been Awarded for the Manufacturing and Filling of Premixed Intravenous Solutions from the FDA (U.S.A.) October 15, 2018 Corporate Grant Offered to Impact Patients and Communities Managing Sickle Cell Disease October 09, 2018 Corporate UniCAR Therapy and Terumo BCT Collaborate to Advance CAR T-Cell Therapies and Create a Shanghai, China Center of Excellence September 19, 2018 Corporate Terumo to Launch the Ultimaster Tansei Drug Eluting Stent in Japan August 29, 2018 Financial Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants) (PDF 71.51 KB) August 16, 2018 Corporate President and CEO of Terumo BCT David Perez to Retire after FY 2018; Antoinette Gawin Named as Successor August 08, 2018 Financial Terumo Revises the First-Half and Full-Year Results Forecast for FY2018 (PDF 210.41 KB) August 08, 2018 Financial Notice Concerning the Issuance of Stock Options (Share Warrants) (PDF 156.72 KB) August 06, 2018 Corporate Terumo's Affiliate in China to Receive an Approval for PD solution July 31, 2018 Corporate Terumo Announces Receiving European Medicines Agency GMP Certification for the Manufacturing and Filling of Biologics in PLAJEX™ Polymer Pre-fillable Syringes at Yamaguchi Subsidiary's Plant July 24, 2018 Corporate Terumo Acquires China-based Essen Technology To Enter Drug-eluting Stent Market in China July 18, 2018 Corporate U.S. FDA Approves Terumo BCT's Sodium Citrate 4% w/v Anticoagulant Solution Amid Shortage July 09, 2018 Corporate Terumo to Increase Production Capacity for Alliance Business Pre-filled Syringes Capital Investment of 7 Billion Yen in Terumo Yamaguchi D&D Corporation July 05, 2018 Corporate Terumo Enters an Exclusive Distribution Relationship for Japan with Piramal Critical Care for Fentanyl Injection, a Prescription-only Narcotic Analgesic for Postoperative Pain Management July 04, 2018 Corporate Terumo Announces Shipping Delays for Products from Ashitaka Factory June 22, 2018 Corporate Terumo Announces Voting Results for the Election of Directors (PDF 199.06 KB) June 20, 2018 Corporate Terumo Acquires CE Marking for Kanshas Drug Coated Balloon Catheter for Lower Extremities June 19, 2018 Corporate New data demonstrate clinical experience with LifePearl microspheres in over 300 hepatocellular carcinoma patients June 12, 2018 Corporate MicroVention Announces FDA Clearance for Thrombectomy Device SOFIA® Catheter; A New Device for the Revascularization of Patients with Acute Ischemic Stroke May 31, 2018 Corporate MicroVention® Announces FDA Approval for Neuro Stent Device The LVIS® and LVIS® Jr. stents are the first stents PMA approved for stent-assisted coil embolization May 24, 2018 Corporate Terumo to Launch the Ultimaster Tansei Drug Eluting Stent in Europe May 11, 2018 Corporate Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow May 09, 2018 Financial Terumo Revises Upward Dividends for the Fiscal Year Ended March 31, 2018 (PDF 205 KB) May 09, 2018 Corporate Terumo Appoints the Candidates for Directors (PDF 197.37 KB) May 07, 2018 Corporate Terumo to Distribute Dexcom's Continuous Glucose Monitoring Systems in Japan April 30, 2018 Corporate First U.S. Clinical Trial Evaluating Red Blood Cells Derived From Pathogen-Reduced Whole Blood Begins April 30, 2018 Corporate Terumo Aortic Announces the First Implants of the Relay®Branch Thoracic Stent-Graft System Early Feasibility Study April 25, 2018 Corporate Terumo Acquires CE Marking for Ultimaster Tansei Drug Eluting Stent Available in Europe Starting in May April 24, 2018 Corporate Terumo Aortic Announces European Launch of Relay®Pro Thoracic Stent Graft System at Charing Cross 2018 April 23, 2018 Corporate Vascutek and Bolton Medical Merge as 'Terumo Aortic' - New company brings together two leaders in the aortic implant market- New identity underlines global growth ambitions further to $43m factory investment- Merger unites two world-class innovators focused on expanding aortic treatment options April 12, 2018 Corporate Terumo and Quirem Welcome the Positive Reimbursement Decision for QuiremSpheres® in the Netherlands March 02, 2018 Corporate Terumo Acquires Large Bore Vascular Closure Device to Expand Its Interventional Access Device Business in the Fast Growing Segment February 26, 2018 Corporate Terumo Pharmaceutical Solutions wins Asia-Pacific Industry Award February 24, 2018 Corporate New Collaboration with StafaCT Will Optimize Patient Pathways for Cellular Treatments February 13, 2018 Corporate Terumo Announces £33m Investment in Scottish Medical Device Factory February 08, 2018 Financial Terumo Revises the Full-Year Results Forecast for FY2017 (PDF 205.85 KB) January 29, 2018 Corporate Terumo Integrates Two R&D Facilities in Silicon Valley to Accelerate Development of Innovative Medical Devices January 25, 2018 Corporate Terumo Announces Change of Directors and Executive Officers (PDF 198.89 KB) January 19, 2018 Corporate Approval of LifePearl® Microspheres as a Class III device in Europe Pagination Previous page ‹ Current page1 Next page ›
December 07, 2018 Corporate Terumo Announces European Launch of Biosimilar Using Terumo's PLAJEX™ Pre-fillable Syringes
November 14, 2018 Corporate Terumo Cardiovascular Group Announces 510(k) Clearance for the CDI® Blood Parameter Monitoring System 550, Adding New Parameter for Oxygen Delivery Monitoring oxygen delivery helps reduce the incidence of Acute Kidney Injury during cardiac surgery
November 14, 2018 Corporate Terumo Announces GMP Certification Has Been Awarded for the Manufacturing and Filling of Premixed Intravenous Solutions from the FDA (U.S.A.)
October 15, 2018 Corporate Grant Offered to Impact Patients and Communities Managing Sickle Cell Disease
October 09, 2018 Corporate UniCAR Therapy and Terumo BCT Collaborate to Advance CAR T-Cell Therapies and Create a Shanghai, China Center of Excellence
August 29, 2018 Financial Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants) (PDF 71.51 KB)
August 16, 2018 Corporate President and CEO of Terumo BCT David Perez to Retire after FY 2018; Antoinette Gawin Named as Successor
August 08, 2018 Financial Terumo Revises the First-Half and Full-Year Results Forecast for FY2018 (PDF 210.41 KB)
August 08, 2018 Financial Notice Concerning the Issuance of Stock Options (Share Warrants) (PDF 156.72 KB)
July 31, 2018 Corporate Terumo Announces Receiving European Medicines Agency GMP Certification for the Manufacturing and Filling of Biologics in PLAJEX™ Polymer Pre-fillable Syringes at Yamaguchi Subsidiary's Plant
July 24, 2018 Corporate Terumo Acquires China-based Essen Technology To Enter Drug-eluting Stent Market in China
July 18, 2018 Corporate U.S. FDA Approves Terumo BCT's Sodium Citrate 4% w/v Anticoagulant Solution Amid Shortage
July 09, 2018 Corporate Terumo to Increase Production Capacity for Alliance Business Pre-filled Syringes Capital Investment of 7 Billion Yen in Terumo Yamaguchi D&D Corporation
July 05, 2018 Corporate Terumo Enters an Exclusive Distribution Relationship for Japan with Piramal Critical Care for Fentanyl Injection, a Prescription-only Narcotic Analgesic for Postoperative Pain Management
June 22, 2018 Corporate Terumo Announces Voting Results for the Election of Directors (PDF 199.06 KB)
June 20, 2018 Corporate Terumo Acquires CE Marking for Kanshas Drug Coated Balloon Catheter for Lower Extremities
June 19, 2018 Corporate New data demonstrate clinical experience with LifePearl microspheres in over 300 hepatocellular carcinoma patients
June 12, 2018 Corporate MicroVention Announces FDA Clearance for Thrombectomy Device SOFIA® Catheter; A New Device for the Revascularization of Patients with Acute Ischemic Stroke
May 31, 2018 Corporate MicroVention® Announces FDA Approval for Neuro Stent Device The LVIS® and LVIS® Jr. stents are the first stents PMA approved for stent-assisted coil embolization
May 11, 2018 Corporate Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow
May 09, 2018 Financial Terumo Revises Upward Dividends for the Fiscal Year Ended March 31, 2018 (PDF 205 KB)
April 30, 2018 Corporate First U.S. Clinical Trial Evaluating Red Blood Cells Derived From Pathogen-Reduced Whole Blood Begins
April 30, 2018 Corporate Terumo Aortic Announces the First Implants of the Relay®Branch Thoracic Stent-Graft System Early Feasibility Study
April 25, 2018 Corporate Terumo Acquires CE Marking for Ultimaster Tansei Drug Eluting Stent Available in Europe Starting in May
April 24, 2018 Corporate Terumo Aortic Announces European Launch of Relay®Pro Thoracic Stent Graft System at Charing Cross 2018
April 23, 2018 Corporate Vascutek and Bolton Medical Merge as 'Terumo Aortic' - New company brings together two leaders in the aortic implant market- New identity underlines global growth ambitions further to $43m factory investment- Merger unites two world-class innovators focused on expanding aortic treatment options
April 12, 2018 Corporate Terumo and Quirem Welcome the Positive Reimbursement Decision for QuiremSpheres® in the Netherlands
March 02, 2018 Corporate Terumo Acquires Large Bore Vascular Closure Device to Expand Its Interventional Access Device Business in the Fast Growing Segment
February 24, 2018 Corporate New Collaboration with StafaCT Will Optimize Patient Pathways for Cellular Treatments
January 29, 2018 Corporate Terumo Integrates Two R&D Facilities in Silicon Valley to Accelerate Development of Innovative Medical Devices
January 25, 2018 Corporate Terumo Announces Change of Directors and Executive Officers (PDF 198.89 KB)